CU6 — Clarity Pharmaceuticals Balance Sheet
0.000.00%
- AU$734.66m
- AU$623.46m
- 36
- 18
- 15
- 11
Annual balance sheet for Clarity Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.27 | 18.9 | 92.3 | 65 | 137 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.66 | 3.37 | 6.66 | 10 | 12.6 |
Prepaid Expenses | |||||
Total Current Assets | 9.05 | 22.5 | 99.6 | 76.7 | 154 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.05 | 0.093 | 0.26 | 0.206 | 0.555 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 9.12 | 22.6 | 99.8 | 76.9 | 155 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.947 | 2.25 | 7.51 | 7.54 | 8.09 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.956 | 2.34 | 7.59 | 7.72 | 8.33 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 8.16 | 20.3 | 92.2 | 69.2 | 146 |
Total Liabilities & Shareholders' Equity | 9.12 | 22.6 | 99.8 | 76.9 | 155 |
Total Common Shares Outstanding |